An approximation of herd effect due to vaccinating children against seasonal influenza – a potential solution to the incorporation of indirect effects into static models

BMC Infectious Diseases

Barbara Poulsen Nautrup³  Genevieve Meier²  Laure-Anne Van Bellinghen¹  Ilse Van Vlaenderen¹ 

[1] CHESS, Kerkstraat 27, 1742, Ternat, Belgium;Health Economics, GlaxoSmithKline Vaccines, 2301 Renaissance Boulevard, RN 0220, King of Prussia, PA, 19406, USA;EAH-Consulting, Heimbacher Str. 19, 52428, Juelich, Germany

关键词: Economic evaluation;    Modelling;    Herd immunity;    Herd effect;    Herd protection;    Influenza;    Vaccination;    Paediatric;   

Others  :  1158559
DOI  :  10.1186/1471-2334-13-25

 received in 2012-05-17, accepted in 2013-01-14,  发布年份 2013

【 摘 要 】

Background

Indirect herd effect from vaccination of children offers potential for improving the effectiveness of influenza prevention in the remaining unvaccinated population. Static models used in cost-effectiveness analyses cannot dynamically capture herd effects. The objective of this study was to develop a methodology to allow herd effect associated with vaccinating children against seasonal influenza to be incorporated into static models evaluating the cost-effectiveness of influenza vaccination.

Methods

Two previously published linear equations for approximation of herd effects in general were compared with the results of a structured literature review undertaken using PubMed searches to identify data on herd effects specific to influenza vaccination. A linear function was fitted to point estimates from the literature using the sum of squared residuals.

Results

The literature review identified 21 publications on 20 studies for inclusion. Six studies provided data on a mathematical relationship between effective vaccine coverage in subgroups and reduction of influenza infection in a larger unvaccinated population. These supported a linear relationship when effective vaccine coverage in a subgroup population was between 20% and 80%. Three studies evaluating herd effect at a community level, specifically induced by vaccinating children, provided point estimates for fitting linear equations. The fitted linear equation for herd protection in the target population for vaccination (children) was slightly less conservative than a previously published equation for herd effects in general. The fitted linear equation for herd protection in the non-target population was considerably less conservative than the previously published equation.

Conclusions

This method of approximating herd effect requires simple adjustments to the annual baseline risk of influenza in static models: (1) for the age group targeted by the childhood vaccination strategy (i.e. children); and (2) for other age groups not targeted (e.g. adults and/or elderly). Two approximations provide a linear relationship between effective coverage and reduction in the risk of infection. The first is a conservative approximation, recommended as a base-case for cost-effectiveness evaluations. The second, fitted to data extracted from a structured literature review, provides a less conservative estimate of herd effect, recommended for sensitivity analyses.

【 授权许可】

   
2013 Van Vlaenderen et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Pitman RJ, Melegaro A, Gelb D, Siddiqui MR, Gay NJ, Edmunds WJ: Assessing the burden of influenza and other respiratory infections in England and Wales. J Infect 2007, 54:530-538.
• [2]McBean AM, Hebert PL: New estimates of influenza-related pneumonia and influenza hospitalizations among the elderly. Int J Infect Dis 2004, 8:227-235.
• [3]World Health Organization: Influenza (Seasonal). Fact Sheet No 211. http://www.who.int/mediacentre/factsheets/fs211/en/ webcite. 2009. 4-1-2012. Ref Type: Electronic Citation
• [4]Department of Health: Summary of flu immunisation policy. http://www.dh.gov.uk/en/Publichealth/Flu/Flugeneralinformation/DH_4001688 webcite. 10-9-2010. 16-4-2011. Ref Type: Electronic Citation
• [5]Postma MJ, Baltussen RM, Heijnen ML, de Berg LT, Jager JC: Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence. Drugs Aging 2000, 17:217-227.
• [6]Glezen WP: Control of influenza. Tex Heart Inst J 2004, 31:39-41.
• [7]Goodwin K, Viboud C, Simonsen L: Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169.
• [8]Kim TH, Johnstone J, Loeb M: Vaccine herd effect. Scand J Infect Dis 2011, 43:683-689.
• [9]Heikkinen T: Influenza in children. Acta Paediatr 2006, 95:778-784.
• [10]Jordan R, Connock M, Albon E, Fry-Smith A, Olowokure B, Hawker J, et al.: Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine 2006, 24:1047-1062.
• [11]Loeb M, Russell ML, Moss L, Fonseca K, Fox J, Earn DJ, et al.: Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA 2010, 303:943-950.
• [12]Bauch CT, Anonychuk AM, Van Effelterre T, Pham BZ, Merid MF: Incorporating herd immunity effects into cohort models of vaccine cost-effectiveness. Med Decis Making 2009, 29:557-569.
• [13]Pradas-Velasco R, Antonanzas-Villar F, Martinez-Zarate MP: Dynamic modelling of infectious diseases: an application to the economic evaluation of influenza vaccination. Pharmacoeconomics 2008, 26:45-56.
• [14]World Health Organization: WHO guide for standardization of economic evaluations of immunization programmes. http://www.who.int/immunization_financing/tools/who_ivb_08_14_en.pdf webcite. 2008. World Health Organization, Department of Immunization, Vaccines and Biologicals, Geneva, Switzerland. Ref Type: Electronic Citation
• [15]Diazgranados CA, Denis M, Plotkin S: Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: A systematic review with meta-analyses of controlled trials. Vaccine 2012, 31:49-57.
• [16]Kemmer G, Keller S: Nonlinear least-squares data fitting in Excel spreadsheets. Nat Protoc 2010, 5:267-281.
• [17]Monto AS, Davenport FM, Napier JA, Francis T Jr: Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic. Bull World Health Organ 1969, 41:537-542.
• [18]Monto AS, Davenport FM, Napier JA, Francis T Jr: Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 1970, 122:16-25.
• [19]Milne G, Kelso J, Kelly H: Strategies for mitigating an influenza pandemic with pre-pandemic H5N1 vaccines. J R Soc Interface 2010, 7:573-586.
• [20]Lemaitre M, Meret T, Rothan-Tondeur M, Belmin J, Lejonc JL, Luquel L, et al.: Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial. J Am Geriatr Soc 2009, 57:1580-1586.
• [21]Rudenko LG, Slepushkin AN, Monto AS, Kendal AP, Grigorieva EP, Burtseva EP, et al.: Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod. Russia. J Infect Dis 1993, 168:881-887.
• [22]van den Dool C, Bonten MJ, Hak E, Heijne JC, Wallinga J: The effects of influenza vaccination of health care workers in nursing homes: insights from a mathematical model. PLoS Med 2008, 5:e200.
• [23]Elveback LR, Fox JP, Ackerman E, Langworthy A, Boyd M, Gatewood L: An influenza simulation model for immunization studies. Am J Epidemiol 1976, 103:152-165.
• [24]Halloran ME, Longini IM, Cowart DM, Nizam A: Community interventions and the epidemic prevention potential. Vaccine 2002, 20:3254-3262.
• [25]Weycker D, Edelsberg J, Halloran ME, Longini IM Jr, Nizam A, Ciuryla V, et al.: Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005, 23:1284-1293.
• [26]Glezen WP, Gaglani MJ, Kozinetz CA, Piedra PA: Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants. J Infect Dis 2010, 202:1626-1633.
• [27]Piedra PA, Gaglani MJ, Kozinetz CA, Herschler G, Riggs M, Griffith M, et al.: Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005, 23:1540-1548.
• [28]Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, et al.: Trivalent live attenuated intranasal influenza vaccine administered during the 2003–2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics 2007, 120:e553-e564.
• [29]Vynnycky E, Pitman R, Siddiqui R, Gay N, Edmunds WJ: Estimating the impact of childhood influenza vaccination programmes in England and Wales. Vaccine 2008, 26:5321-5330.
• [30]Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB: Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis 1991, 163:300-304.
• [31]Esposito S, Marchisio P, Cavagna R, Gironi S, Bosis S, Lambertini L, et al.: Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households. Vaccine 2003, 21:3162-3168.
• [32]Ghendon YZ, Kaira AN, Elshina GA: The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol Infect 2006, 134:71-78.
• [33]Gruber WC, Taber LH, Glezen WP, Clover RD, Abell TD, Demmler RW, et al.: Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child 1990, 144:595-600.
• [34]Hurwitz ES, Haber M, Chang A, Shope T, Teo S, Ginsberg M, et al.: Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 2000, 284:1677-1682.
• [35]Principi N, Esposito S, Marchisio P, Gasparini R, Crovari P: Socioeconomic impact of influenza on healthy children and their families. Pediatr Infect Dis J 2003, 22:S207-S210.
• [36]Marchisio P, Baggi E, Bianchini S, Principi N, Esposito S: Clinical and socioeconomic impact of pediatric seasonal and pandemic influenza. Hum Vaccin Immunother 2012, 8:17-20.
• [37]Lunelli A, Rizzo C, Puzelli S, Bella A, Montomoli E, Rota MC, et al.: Understanding the dynamics of seasonal influenza in Italy: incidence, transmissibility and population susceptibility in a 9-year period. Influenza Other Respi Viruses 2012.
• [38]Bansal S, Pourbohloul B, Meyers LA: A comparative analysis of influenza vaccination programs. PLoS Med 2006, 3:e387.
• [39]Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al.: Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008, 5:e74.